0001104659-18-059112.txt : 20180927 0001104659-18-059112.hdr.sgml : 20180927 20180927163103 ACCESSION NUMBER: 0001104659-18-059112 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andrews Kurt J. CENTRAL INDEX KEY: 0001636133 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 181091290 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 3 1 a3.xml 3 X0206 3 2018-09-24 0 0000722830 IMMUNOMEDICS INC IMMU 0001636133 Andrews Kurt J. C/O IMMUNOMEDICS 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 0 1 0 0 CHIEF HUMAN RESOURCES OFFICER Stock Option (right to buy) 24.76 2019-07-11 2025-07-11 Common Stock, par value $0.01 per share 76222 D The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter. On September 24, 2018, the Issuer appointed the Reporting Person as the Issuer's Chief Human Resources Officer. /s/ Kurt Andrews 2018-09-27